These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13864923)

  • 1. Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256.
    BARCLAY M; GARFINKEL E; TEREBUS-KEKISH O; SHAH EB; DEGUIA M; BARCLAY RK; SKIPSKI VP
    Arch Biochem Biophys; 1962 Sep; 98():397-405. PubMed ID: 13864923
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-density lipoproteins and lipoprotein lipase activity in tissues from rats bearing Walker carcinosarcoma 256.
    BARCLAY M; CALATHES DN; GARFINKEL E; TEREBUSKEKISH O; BARCLAY RK; SKIPSKI VP
    Arch Biochem Biophys; 1962 Sep; 98():391-6. PubMed ID: 13864922
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenobarbital markedly increases liver weight in Walker carcinosarcoma bearing rats.
    KATO R; FRONTINO G; VASSANELLI P
    Experientia; 1963 Jan; 19():30-1. PubMed ID: 13958400
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased activities of liver microsomal drug-metabolizing enzymes in the rats bearing Walker carcinosarcoma.
    KATO R; FRONTINO G; VASSANELLIP
    Experientia; 1963 Jan; 19():31-2. PubMed ID: 13958401
    [No Abstract]   [Full Text] [Related]  

  • 5. PROTEIN RESERVES AND GROWTH OF THE WALKER CARCINOSARCOMA IN RATS.
    Wannemacher RW; Yatvin MB
    J Nutr; 1965 Apr; 85(4):393-9. PubMed ID: 14273740
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth suppression of subcutaneously inoculated hepatic tumors after injection of syngeneic liver cells into the subcutaneous tissue of rats.
    Kamei H; Kondo T; Momoi T; Terabe K; Sugimoto K
    J Natl Cancer Inst; 1976 Feb; 56(2):415-7. PubMed ID: 176387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
    Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
    Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and purification of RP2-L, a nuclear protein fraction of the Walker 256 carcinosarcoma.
    BUSCH H; HNILICA LS; CHIEN SC; DAVIS JR; TAYLOR CW
    Cancer Res; 1962 Jun; 22():637-45. PubMed ID: 13875101
    [No Abstract]   [Full Text] [Related]  

  • 9. ISOLATION OF NUCLEOLI OF THE WALKER CARCINOSARCOMA AND LIVER OF THE RAT FOLLOWING NUCLEAR DISRUPTION IN A FRENCH PRESSURE CELL.
    DESJARDINS R; SMETANA K; STEELE WJ; BUSCH H
    Cancer Res; 1963 Dec; 23():1819-23. PubMed ID: 14082878
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON THE COMPOSITION OF NUCLEAR RESIDUAL PROTEINS FROM RAT LIVER AND WALKER 256 CARCINOSARCOMA.
    STEELE WJ; BUSCH H
    Exp Cell Res; 1964 Jan; 33():68-73. PubMed ID: 14109154
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of "aging" in reducing the development of tumors after inoculation of carcinosarcoma 256 Walker cells.
    CHAN PY; HADDEN DH; McDONALD GO; COLE WH
    Cancer; 1961; 14():1057-9. PubMed ID: 13692268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basic and salvage pathways of NAD biosynthesis in organs of normal rats, tumor-bearing rats and in tumors].
    Reztsova VV; Filov VA; Ivin BA; Kon'kov SA; Krylova IM
    Vopr Onkol; 1994; 40(1-3):68-71. PubMed ID: 7701797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Test of multi-step-therapy of cancer (combination of pretreatment with glucose with chemotherapy and whole body hyperthermia) in Walker- and DS-carcinosarcoma of rat (author's transl)].
    Heinrich M; Osswald H
    Arch Geschwulstforsch; 1974; 43(4):310-9. PubMed ID: 4429424
    [No Abstract]   [Full Text] [Related]  

  • 14. [RESEARCH ON THE INFLUENCE OF DIVERSE SURGICAL INTERVENTIONS ON THE METASTASIS OF WALKER'S CARCINOSARCOMA].
    DEVECCHIPELLATI M; BARBIERI A
    Minerva Chir; 1964 Oct; 19():723-4. PubMed ID: 14227551
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of carcinosarcoma Walker 256 in the experimental chemotherapy of cancer].
    BERGEL M
    Sem Med; 1956 Aug; 109(10):399-403. PubMed ID: 13380493
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic catalase in rats bearing Walker tumor in the brain.
    Gershbein LL
    J Surg Oncol; 1980; 15(4):349-53. PubMed ID: 7453184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the transformation of Walker carcinosarcoma 256 into an ascitic form in the rat].
    MOR C; SFORZA M; DE VECCHI PELLATI M
    Tumori; 1960; 46():525-8. PubMed ID: 13772388
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcass weight changes in rats bearing Walker carcinosarcoma 256.
    KAMPSCHMIDT RF; McCOY TA
    Proc Soc Exp Biol Med; 1959 Jul; 101(3):507-9. PubMed ID: 13675299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of blood proteins and lipoproteins in Walker carcinosarcoma-bearing rats].
    GARATTINI S; MOR C; MURELLI B
    G Ital Chemioter; 1956; 3(1-2):68-71. PubMed ID: 13366001
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of varying implant cell numbers on the inhibitory activity of guinea pig serum on Walker carcinosarcoma 256 in the rat.
    KWAK KS; JAMESON E; RYAN RM; KURTZ HM
    Cancer Res; 1961 Jan; 21():44-7. PubMed ID: 13755546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.